Investors are delving into the details on shares of Neurocrine Bioscienc (NBIX). The share price has felt recent pressure moving past the Stochtastic Momentum Index of -40, indicating possible oversold territory.
The Stochastic Momentum Index, or SMI, is a more refined version of the original stochastic oscillator, employing a wider range of values and having a higher sensitivity to closing prices. The Stochastic Momentum Index (SMI) indicator was developed by William Blau and is based on the Stochastic indicator. The Stochastic oscillator is calculated using the close price relative to the high low trading range, whereas the Stochastic Momentum Index indicator is calculated using the close price relative to the midpoint of the high low trading range. The most common method of using SMI is to look for buy trades when the SMI falls under -40 and then rises back above through -40. Sell trades are looked for when the SMI rises above +40 and then falls back below +40.
Investors often have to figure out how aggressive they want to be when getting into the stock market. There are individuals who may have had some initial success based on random luck, but diving without preparation can leave investors on the short end of the stick in the long run. Investors may be tempted by the next hot stock that is being talked about around the water cooler. Investors might not realize how risky a certain stock may be, and they may find out that the over performer has already made the run. Doing all the homework may involve tracking technicals, fundamentals, current economic data, and earnings releases. Putting in the time to do the proper research may help the investor see profits down the road.
Currently, the 14-day ADX for Neurocrine Bioscienc (NBIX) is 21.95. Generally speaking, an ADX value from 0-25 would indicate an absent or weak trend. A value of 25-50 would indicate a strong trend. A value of 50-75 would signal a very strong trend, and a value of 75-100 would indicate an extremely strong trend. The Average Directional Index or ADX is a technical analysis indicator used to describe if a market is trending or not trending. The ADX alone measures trend strength but not direction. Using the ADX with the Plus Directional Indicator (+DI) and Minus Directional Indicator (-DI) may help determine the direction of the trend as well as the overall momentum. Many traders will use the ADX alongside other indicators in order to help spot proper trading entry/exit points.
Neurocrine Bioscienc (NBIX) presently has a 14-day Commodity Channel Index (CCI) of -197.45. Typically, the CCI oscillates above and below a zero line. Normal oscillations tend to stay in the range of -100 to +100. A CCI reading of +100 may represent overbought conditions, while readings near -100 may indicate oversold territory. Although the CCI indicator was developed for commodities, it has become a popular tool for equity evaluation as well. The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of stock price movements. The RSI was developed by J. Welles Wilder, and it oscillates between 0 and 100. Generally, the RSI is considered to be oversold when it falls below 30 and overbought when it heads above 70. RSI can be used to detect general trends as well as finding divergences and failure swings. The 14-day RSI is currently at 36.10, the 7-day stands at 22.06, and the 3-day is sitting at 4.44.
Taking a peek at some Moving Averages, the 200-day is at 97.03, and the 50-day is 83.70. Dedicated investors may be looking to employ another tool for doing technical stock analysis. The Williams Percent Range or Williams %R is a technical indicator that was designed to measure overbought and oversold market conditions. The Williams %R indicator helps show the relative situation of the current price close to the period being observed. Neurocrine Bioscienc (NBIX)’s Williams Percent Range or 14 day Williams %R presently is at -94.47. In general, if the reading goes above -20, the stock may be considered to be overbought. Alternately, if the indicator goes under -80, this may show the stock as being oversold.
Investors may be scouring the exchanges for the next breakout stock. With the next earnings season in focus, investors will be keeping their eyes open for names that have upside potential. Tracking earnings results can help the investor see how healthy the company is. Investors may choose to research companies that produce large earnings beats. Taking the time to fully research the fundamentals can help the investor start piecing together the puzzle. Although many investors may not feel comfortable making trades around earnings, they can prepare for the aftermath and set up a plan to proceed once the market settles.